Experience of entecavir in renal graft recipients with chronic hepatitis B
Aim of investigation. To estimate efficacy and safety of entecavir (ETV) in chronic hepatitis B (CHB) at renal graft recipients (RGR).Material and methods. Four RGR with CHB on in mean 71,5±36,9 month after kidney transplantation received treatment by entecavir. In 2 patients with CHB biochemical re...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2011-09-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1450 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|